An Open label extension study of GBT440 administered orally to patients with sickle cell disease who have participated in GBT440 clinical trials
Clinical Trial Grant
Administered By
Medicine, Hematology
Awarded By
Global Blood Therapeutics, Inc.
Start Date
May 9, 2018
End Date
April 30, 2022
Administered By
Medicine, Hematology
Awarded By
Global Blood Therapeutics, Inc.
Start Date
May 9, 2018
End Date
April 30, 2022